Debating the oncologist's role in defining the value of cancer care: We have a duty to society

Journal of Clinical Oncology

Volumn 32, Issue 36, 2014, Pages 4035-4038

  Jagsi, Reshma ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; NEOPLASM; NOTE; ONCOLOGIST; PHYSICIAN ATTITUDE; UNITED STATES; ECONOMICS; HEALTH CARE ORGANIZATION; NEOPLASMS; ONCOLOGY;

HEALTH CARE COSTS; HEALTH CARE RATIONING; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PHYSICIAN'S ROLE;

EID: 84919711795     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.1587     Document Type: Note

References (55)

1. Levit LA, Balogh EP, Nass SJ, et al (eds): Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. Washington, DC, The National Academies Press, 2013
2. National Research Council: Aging and the macroeconomy: Long-term implications of an older population. Washington, DC, The National Academies Press, 2012
3. Organisation for Economic Cooperation and Development (OECD): Health at a glance 2011: OECD indicators. Paris, France, OECD Publishing, 2011 http://dx.doi.org/10.1787/health-glance-2011-en
4. Centers for Medicare & Medicaid Services: National Health Expenditure Data: Historical. Updated January 2014. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsHistorical.html
5. Fuchs VR: The gross domestic product and health care spending. N Engl J Med 369:107-109, 2013
6. Sullivan R, Peppercorn J, Sikora K, et al: Delivering affordable cancer care in high-income countries. Lancet Oncol 12:933-980, 2011
7. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-128, 2011
8. Earle CC, Neville BA, Landrum MB, et al: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321, 2004
9. Sharma G, Freeman J, Zhang D, et al: Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest 133:72-78, 2008
10. Agency for Healthcare Research and Quality: 2007 National Healthcare Quality Report. Rockville, MD, U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality, AHRQ publication No. 08-0040, 2008
11. Malin JL: Wrestling with the high price of cancer care: Should we control costs by individuals' ability to pay or society's willingness to pay? J Clin Oncol 28:3212-3214, 2010
12. Chernew ME, Baicker K, Hsu J: The specter of financial Armageddon: Health care and federal debt in the United States. N Engl J Med 362:1166-1168, 2010
13. Baicker K, Skinner JS: Health care spending growth and the future of U.S. tax rates. Tax Policy Economy 25:39-68, 2011
14. Ubel PA, Jagsi R: Promoting population health through financial stewardship. N Engl J Med 370:1280-1281, 2014
15. Brody H: Medicine's ethical responsibility for health care reform: The Top Five list. N Engl J Med 362:283-285, 2010
16. Ramsey SD, Ganz PA, Shankaran V, et al: Addressing the American health-care cost crisis: Role of the oncology community. J Natl Cancer Inst 105:1777-1781, 2013
17. Starr P: The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry. New York, NY, Basic Books, 1984
18. Kant I: Foundations of the Metaphysics of Morals. Beck, LW (trans). Indianapolis, IN, Bobbs-Merrill, 1959
19. Brennan TA: Just Doctoring: Medical Ethics in the Liberal State. Berkeley, CA, University of California Press, 1991
20. Daniels N: Just Health Care: Studies in Philosophy and Health Policy. Cambridge, United Kingdom, Cambridge University Press, 1985
21. Callahan D: Rationing: Theory, politics, and passions. Hastings Cent Rep 41:23-27, 2011
22. Aaron HJ, Schwartz WB: The Painful Prescription: Rationing Hospital Care. Washington, DC, Brookings Institution Press, 1984
23. Aaron HJ, Schwartz WB: Can We Say NO? The Challenge of Rationing Health Care. Washington, DC, Brookings Institution Press, 2005
24. Ubel PA: Pricing Life: Why it's Time for Health Care Rationing. Cambridge, MA, The MIT Press, 2001
25. Sorenson C, Drummond M, Chalkidou K: Comparative effectiveness research: The experience of the National Institute for Health and Clinical Excellence. J Clin Oncol 30:4267-4274, 2012
26. Boulis A, Goold S, Ubel PA: Responding to the immunoglobulin shortage: A case study. J Health Polit Policy Law 27:977-999, 2002
27. Health Resources and Services Administration, Organ Procurement and Transplantation Network: Organ Distribution: Allocation of Deceased Kidneys. September 2012 update. http://optn.transplant.hrsa.gov/ContentDocuments/OPTN-Policies-Old-.pdf
28. Scribner BH: Lasker Clinical Medicine Research Award: Medical dilemmas - The old is new. Nat Med 8:1066-1067, 2002
29. Jagsi R, DeLaney TF, Donelan K, et al: Real-time rationing of scarce resources: The Northeast Proton Therapy Center experience. J Clin Oncol 22:2246-2250, 2004
30. Strosberg MA, Wiener JM, Baker R, et al: (eds): Rationing America's Medical Care: The Oregon Plan and Beyond. Washington, DC, The Brookings Institution, 1992
31. Bentham J: An Introduction to the Principles of Morals and Legislation. London, United Kingdom, Athlone Press, 1970
32. Mill JS: Utilitarianism. Oxford, United Kingdom, Oxford University Press, 1998
33. Kaplan R: A quality-of-life approach to health resource allocation, in Strosberg M, Wiener J, Baker R, et al (eds): Rationing America's Medical Care: The Oregon Plan and Beyond. Washington, DC, The Brookings Institution, 1992
34. Hadorn DC: Setting health care priorities in Oregon: Cost-effectiveness meets the rule of rescue. JAMA 265:2218-2225, 1991
35. Government Printing Office: The Patient Protection and Affordable Care Act. Public Law 111-148. March 23, 2010 http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf
36. Neumann PJ, Weinstein MC: Legislating against use of cost-effectiveness information. N Engl J Med 363:1495-1497, 2010
37. Gutmann A, Thompson D: Deliberating about bioethics. Hastings Cent Rep 27:38-41, 1997
38. Goold SD, Biddle AK, Klipp G, et al: Choosing Healthplans All Together: A deliberative exercise for allocating limited health care resources. J Health Polit Policy Law 30:563-601, 2005
39. Newcomer LN: Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs. Health Aff (Millwood) 31:780-785, 2012
40. Hoverman JR, Cartwright TH, Patt DA, et al: Pathways, outcomes, and costs in colon cancer: Retrospective evaluations in 2 distinct databases. Am J Manag Care 17:SP45-SP52, 2011
41. Neubauer MA, Hoverman JR, Kolodziej M, et al: Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract 6:12-18, 2010
42. US Oncology Network: Level I pathways, 2013. http://www.usoncology.com/cancercareadvocates/AdvancingCancerCare/DeliverHigh-QualityCare/LevelIPathways
43. Bach P, Salz LB, Wittes RE: In cancer care, cost matters. New York Times, October 14, 2012: A25
44. Kantarjian HM, Fojo T, Mathisen M, et al: Cancer drugs in the United States: Justum Pretium - The just price. J Clin Oncol 31:3600-3604, 2013
45. Berwick DM, Hackbarth AD: Eliminating waste in US health care. JAMA 307:1513-1516, 2012
46. Tilburt JC, Cassel CK: Why the ethics of parsimonious medicine is not the ethics of rationing. JAMA 309:773-774, 2013
47. Schnipper LE: The rising cost of cancer care: Physicians take charge. J Oncol Pract 8:e87-e88, 2012
48. Schnipper LE, Lyman GH, Blayney DW, et al: American Society of Clinical Oncology 2013 top five list in oncology. J Clin Oncol 31:4362-4370, 2013
49. Schnipper LE, Smith TJ, Raghavan D, et al: American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol 30:1715-1724, 2012
50. Bernard DS, Farr SL, Fang Z: National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol 29:2821-2826, 2011
51. Jagsi R, Pottow JA, Griffith KA, et al: Long-term financial burden of breast cancer: Experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol 32:1269-1276, 2014
52. Ramsey S, Blough D, Kirchhoff A, et al: Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) 32:1143-1152, 2013
53. Shankaran V, Jolly S, Blough D, et al: Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol 30:1608-1614, 2012
54. Zafar SY, Peppercorn JM, Schrag D, et al: The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 18:381-390, 2013
55. Katz SJ, Morrow, M: The challenge of individualizing treatments for patients with breast cancer. JAMA 307:1379-1380, 2012